Patricia J. Zettler, Jacob S. Sherkow & Henry T. Greely, 23andMe, the Food and Drug Administration, and the Future of Genetic Testing, 174 JAMA Internal Medicine E1-E2 (2014). [Also on SSRN.]
Jacob S. Sherkow, "Medical practice, patents, and ‘custom children’: A look at the future of reproductive medicine," SCOPE, November 14, 2013.
Jacob S. Sherkow, The Natural Complexity of Patent Eligibility, 99 Iowa Law Review 1137 (2014); Stanford Public Law Working Paper No. 2268180 (August 5, 2013).
Jacob S. Sherkow & Henry T. Greely, The Future of Gene Patents and the Implications for Medicine, 173 JAMA Internal Medicine 1569 (2013).
Jake Sherkow, A Closer Look at the Supreme Court's Decision on Gene Patenting, SCOPE [Stanford School of Medicine's blog] (June 13, 2013).
Jake Sherkow, Are genes patentable? A summary of the Supreme Court case, SCOPE [Stanford School of Medicine's blog] (April 16, 2013).
Jacob S. Sherkow & Henry T. Greely, What if Extinction is Not Forever?, Science Magazine (April 5, 2013) 32.
Jacob S. Sherkow, Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements, 31 Nature Biotechnology 316 (2013).
Jacob S. Sherkow, And How: Mayo v. Prometheus and the Method of Invention, 122 Yale L.J. Online 351 (2013).
Jacob S. Sherkow, Don't Worry about Baltimore's Patent Drought, The Baltimore Sun, February 18, 2013.